Company page

Advagene Biopharma Co., Ltd.

Advagene Biopharma Co., Ltd. is a public company listed on the Taiwan stock market under the ticker 6709. The company has a market capitalization of approximately 54.15 million. Advagene focuses on biopharmaceutical development and innovation.

profile6709:TPEXAI content: aiUpdated June 24, 2026/company/advagene-biopharma-co-ltd/c-2lla5sum
Advagene Biopharma Co., Ltd. logo
Ticker
6709:TPEX
Asset type
Stock
Market cap
$54.1M
Sector
Health Technology
Industry
Biotechnology
Exchange
TPEX
Currency
TWD